Adamsen, J., Rundle-Thiele, S., and Whitty, J. (2013). Best-Worst scaling. . .reflections on presentation, analysis, and lessons learnt from case 3 BWS experiments. Market and Social Research, 21, 9–27.
Ballard, C. G., Creese, B., Corbett, A. and Aarsland, D. (2011). Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality. Expert Opinion on Drug Safety, 10, 35–43.
Brodaty, H. and Arasaratnam, C. (2012). Meta-analysis of nonpharmacological interventions for neuropsychiatric symptoms of dementia. American Journal of Psychiatry, 169, 946–953.
et al. (2005). Wisdom from the front lines: clinicians’ descriptions of treating agitation in the nursing home, a pilot study. Journal of the American Medical Directors Association, 6, 257–264.
Cohen-Mansfield, J. and Jensen, B. (2008a). Nursing home physicians' knowledge of and attitudes toward nonpharmacological interventions for treatment of behavioral disturbances associated with dementia. Journal of the American Medical Directors Association, 9, 491–498.
Cohen-Mansfield, J. and Jensen, B. (2008b). Physicians' perceptions of their role in treating dementia-related behavior problems in the nursing home: actual practice and the ideal. Journal of the American Medical Directors Association, 9, 552–557.
Cohen-Mansfield, J., Juravel-Jaffe, A., Cohen, A., Rasooly, I. and Golander, H. (2013). Physicians’ practice and familiarity with treatment for agitation associated with dementia in Israeli nursing homes. International Psychogeriatrics, 25, 236–244.
Corbett, A., Burns, A. and Ballard, C. (2014). Don't use antipsychotics routinely to treat agitation and aggression in people with dementia. BMJ, 349, g6420.
Cornegé-Blokland, E., Kleijer, B. C., Hertogh, C. M. and van Marum, R. J. (2012). Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers. Journal of the American Medical Directors Association, 13, 80. e81–80. e86.
Finn, A. and Louviere, J. J. (1992). Determining the appropriate response to evidence of public concern: the case of food safety. Journal of Public Policy and Marketing, 11, 12–25.
Flynn, T. N., Louviere, J. J., Peters, T. J. and Coast, J. (2008). Estimating preferences for a dermatology consultation using best-worst scaling: comparison of various methods of analysis. BMC Medical Research Methodology, 8, 76.
Gustafsson, M., Karlsson, S. and Lövheim, H. (2013). Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units. BMC Pharmacology and Toxicology, 14, 1.
Jeste, D. V.
et al. (2008). ACNP white paper: update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology, 33, 957–970.
Kleijer, B. C.
et al. (2008). Risk of cerebrovascular events in elderly users of antipsychotics. Journal of Psychopharmacology, 23, 909–914.
Liperoti, R., Pedone, C. and Corsonello, A. (2008). Antipsychotics for the treatment of behavioral and psychological symptoms of dementia (BPSD). Current Neuropharmacology, 6, 117–124.
Louviere, J. J., Lings, I., Islam, T., Gudergan, S. and Flynn, T. (2013). An introduction to the application of (case 1) best–worst scaling in marketing research. International Journal of Research in Marketing, 30, 292–303.
Louviere, J., Flynn, T. and Marley, A. (2015). Best-Worst Scaling: Theory, Methods and Applications. Cambridge: Cambridge University Press.
Lövheim, H., Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2006). Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. International Psychogeriatrics, 18, 713–726.
et al. (2012). Barriers to integrating personalized medicine into clinical practice: a best-worst scaling choice experiment. Genetics in Medicine, 14, 520–526.
Nygaard, H. A., Ruths, S., Straand, J. and Naik, M. (2004). Not less but different: psychotropic drug utilization trends in Norwegian nursing homes during a 12-year period. The Bergen District Nursing Home (BEDNURS) Study. Aging Clinical and Experimental Research, 16, 277–282.
et al. (2014). Family involvement in decision making for people with dementia in residential aged care: a systematic review of quantitative literature. International Journal of Evidence-based Healthcare, 12, 64–86.
et al. (2016). A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany. Therapeutic Advances in Neurological Disorders, 9, 95–104.
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. Journal of the American Medical Association, 294, 1934–1943.
Schumock, G. T.
et al. (2004). Factors that influence prescribing decisions. Annals of Pharmacotherapy, 38, 557–562.
Selbeak, G., Kirkevold, Ø. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843–849.
Smeets, C. H.
et al. (2014). Factors related to psychotropic drug prescription for neuropsychiatric symptoms in nursing home residents with dementia. Journal of the American Medical Directors Association, 15, 835–840.
et al. (2009). Factors influencing prescribing behaviour of physicians in Greece and cyprus: results from a questionnaire based survey. BMC Health Services Research, 9, 150.
Trifiro, G. and Spina, E. (2011). Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Current Drug Metabolism, 12, 611–620.
van der Spek, K.
et al. (2013). PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol. BMC Psychiatry, 13, 307.
van de Ven, G.
et al. (2013). Effects of dementia-care mapping on residents and staff of care homes: a pragmatic cluster-randomised controlled trial. PLoS ONE, 8, e67325.
Vereniging Specialisten Ouderengeneeskunde (2016). Verenso [Online]. Utrecht: VERENSO. Available at: http://www.verenso.nl/; last accessed: 9 February 2016.
Weernink, M. G.
et al. (2014). A systematic review to identify the use of preference elicitation methods in healthcare decision making. Pharmaceutical Medicine, 28, 175–185.
Wood-Mitchell, A., James, I. A., Waterworth, A., Swann, A. and Ballard, C. (2008). Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age and Ageing, 37, 547–552.
et al. (2008). Richtlijn Probleemgedrag [Guideline for the Treatment of Behavioural Disturbances]. Arnhem: Roos en Roos Press.
Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2011). Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians’ prescription behavior. International Psychogeriatrics, 23, 1632–1639.